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Abstract
Background: The HPV vaccination has consistently had lower adherence rates than the goal set
by Healthy People 2020. The Advisory Committee on Immunizations Practices (ACIP) now
recommends that children (both male and female) 11 to 12 years of age should start to receive
the HPV vaccine before exposure to the virus. However, even with the change in the new
guidelines, the HPV vaccine administration rates still trail other adolescent vaccinations.
Purpose: The purpose of this project is to identify pediatric and family practice provider
adherence to ACIP/CDC recommendations on HPV vaccinations in a Southeastern United States
health system in pre-teens and adolescents from ages 11 to 18 years of age.
Methods: A retrospective chart review was performed and 100 charts were randomly selected
from electronic health records from both a family practice and pediatric practice who were seen
from January 1, 2017 through December 31, 2017
Results: There were no significant differences in HPV vaccination rates between the family and
pediatric clinics, number of vaccination doses given, and provider adherence to ACIP/CDC
guidelines. The only statistically significant difference was that the pediatric practice saw a
younger patient population (SD 1.9) compared to the family practice (SD 2.4) (p=0.036).
Conclusion: Even with similar comparisons on provider adherence, both the pediatric and
family practice failed to obtain Healthy Peoples 2020 80% goal for HPV vaccinations. The
pediatric practice was at 68.6 % while family practice was at 55.6%.

Keywords: HPV, HPV Vaccine, Adolescent, Pre-teen, STI, HPV prevention
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Provider Adherence to Recommendations for HPV Vaccination
in a Family Practice and Pediatric Clinic
Introduction
The Human Papillomavirus (HPV) is a very common virus that affects, on average, 14
million people each year in the United States (US) and is spread through sexual contact with
another person (Center of Disease Control and Prevention (CDC), 2015). Currently 80 million
people, or approximately one in every four Americans, are infected with HPV, making it the
most common sexually transmitted infection (STI) in the US (CDC, 2015). Although most HPV
infections resolve spontaneously, some infections can lead to severe, life-threatening
consequences. In addition, HPV infection can cause several different kinds of cancer, including:
cervical (most common), vulvar, and vaginal cancer in women and penile cancer in men (CDC,
2015). HPV is also noted to cause anal and throat cancer as well as genital warts in both men and
women (CDC, 2015). The HPV vaccine offers protection from the HPV virus, and aids in the
protection from cancer caused from the virus itself (CDC, 2016). For women, routine screenings
and pap smears are available to detect most cervical cancers; however, no screening is routine to
detect cancers linked to HPV in men (HHS, 2016). These HPV related diseases can cause
suffering, pain, surgical procedures, hospitalizations, and in worst case scenarios, death
(Sussman et al., 2015).
Background
Despite its strong clinical endorsement by the Advisory Committee on Immunizations
Practices (ACIP), HPV immunization rates among adolescents is considerably less than that of
other vaccines (Sussman et al., 2015). Sussman et. al (2015) demonstrates that
preteen/adolescent vaccinations, such as Tdap and meningococcal vaccines, were above 80 %
2
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coverage yet only 60.4 % (65.1% for females; 56.0% for males), and 43.4% were up to date with
the recommended HPV vaccination series (49.5% for females; 37.5% for males). In order to
reach the Healthy People 2020 goal, HPV vaccination rates need to increase to achieve the 80th
percentile (Healthy People 2020, 2017). It is important to note that despite the lower percentage
of vaccination coverage compared to other vaccinations for this population, the vaccine has been
proven to be effective. In just 4 years after it was recommended to the U.S. public in 2006, HPV
infections in teenaged girls decreased by 56 % in 2010, with a corresponding decrease of HPV
prevalence in women in their 20s (CDC, 2016). Nonetheless, nationally, 6 out of 10 teen aged
girls have received at least one of the vaccines, while 5 out of 10 teen aged boys have received
full HPV vaccination coverage (CDC, 2016). Kentucky (KY) is below the national average of
HPV coverage for both boy and girls with less than 59 % of teenaged girls receiving one or more
doses of the HPV vaccine and less than 39 % of teenaged boys receiving any form of the vaccine
(CDC, 2016). If an 80 % rate of HPV vaccination is accomplished per the standards set by
Healthy People 2020, 53,000 or more cases of cervical cancer or other cancers related to the
virus could be prevented (Gable, Eder, Noonan, & Feemster, 2016).
The Advisory Committee on Immunizations Practices (ACIP) which provides advice and
guidance to the CDC on the use of vaccines recommends that HPV vaccines be routinely
administered to all children at the age 11 to 12 years of age (ACIP, 2016). The ACIP/CDC
(2016) now recommends that children 11 to 12 years of age should be administered two vaccines
6 to 12 months apart. If an adolescent is older than 14 years or has certain immunocompromising
conditions, a total of 3 courses of vaccines will need to be given (CDC, 2016). While HPV
immunization is recommended prior to sexual activity, it is possible for young adult women to
receive the vaccine up to age 26 and young adult males up to 22 years of age (HHS, 2016).
3
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Recently the American Cancer Society (ACS) recommended that the Gardasil 9 vaccine has been
approved for women and men up to age 45, though not recommended after age 26 due to the lack
of benefit in an older population (ACS, 2018). With the update the HPV vaccination guidelines
along with provider adherence to CDC recommendations, cancers and other diseases caused by
the virus can be prevented. The updated ACIP guidelines could provide room for improvement
when it comes to HPV vaccination rates since the vaccination is scheduled to be given around
the same time as other adolescent vaccinations, such as Tdap and meningococcal vaccination
which currently have much higher vaccination rates than HPV. Another selling point with the
newer HPV vaccination guidelines is if the patient gets the vaccination before the age of 15, it is
only a series of two doses instead of three.
Purpose
A systematic review of current research has shown that often times the single biggest
indicator for a parent to choose to have their child immunized with the HPV vaccine is based on
the recommendation of the provider (Scott & Batty, 2016; Shay et al., 2016; Sussman et al.,
2015; Ylitalo, Lee, & Mehta, 2013). Determining rates in both a family and pediatric clinical
setting can help determine if providers are adhering to the HPV vaccination guidelines set by the
ACIP and provide insight if there are any variations on how the vaccine is administered in either
a pediatric or family medicine setting.
The purpose of this project was to evaluate the adherence to ACIP/CDC
recommendations on HPV vaccinations by providers in both a pediatric and a family practice
setting in the Southeastern metro area. The primary objectives were to:

4
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a. Evaluate the adherence of Community Medical Associates family medicine providers
on HPV vaccinations for patient encounters from January 1, 2017 to December 31, 2017
b. Evaluate the adherence of Children Medical Associates providers to on HPV
vaccinations for patient encounters from January 1, 2017 to December 31, 2017
c. Compare the adherence between family medical practice providers to pediatric practice
providers on HPV vaccinations for patient encounters from January 1, 2017 to December 31,
2017.
Conceptual Framework
Andersen’s Behavioral Model was used to analyze why some people choose to vaccinate
their children from HPV and why some choose not to have their child vaccinated. Andersen’s
Behavioral Model provides a framework for understanding how patient’s beliefs/predisposed
factors, as well environmental factors impact health behaviors and outcomes. This model implies
that an individual's access and use of health services is a function of three
characteristics: predisposing factors, enabling factors, and need (Andersen, 1995). Predisposing
factors are socio-cultural characteristics of individuals that exist prior to their illness such as:
race, education, age, gender, attitudes, values, and knowledge that people have concerning and
towards the health care system, etc. Enabling factors are logistical aspects of obtaining care such
as: access to health care services, income, health insurance, a regular source of travel, etc. Lastly,
need is the most immediate cause of health service use, from functional and health problems that
generate the need for health care services (Andersen, 1995). There are two types of needs which
are: perceived need and evaluated need. Andersen (1995) states perceived need will better help
to understand care-seeking and adherence to a medical regimen (such as immunizations), while
5

PROVIDER ADHERENCE TO RECOMMENDATIONS
evaluated need is related to the kind of treatment that will be provided after a patient has
presented to a medical care provider with a problem/illness.
Methods
Design
A descriptive study design was used to guide this retrospective chart audit to explore the
level of provider adherence to ACIP/CDC HPV vaccination guidelines for pre-teen and
adolescents.
Sample
The sample for this study was based on a retrospective review of patient immunization
records at both the family practice clinic and pediatric clinic for the period January 1st, 2017 to
December 31st, 2017. Inclusion criteria were patient electronic medical records (EMRs) for
patients aged 11 to 18 years old; male or female genders, who were patients seen at either the
family practice or pediatric practice within the time period. Exclusion criteria were female and
male patients between the ages 11 to18 years who had already completed the vaccination series
before January 1, 2017 or who had contraindications to receiving the vaccine due to patient
allergies. The sample contained all adolescent patients who received an office encounter with a
provider at either clinical practice sites during the time period from January 1st to December
31st, 2017. The EMRs for the population of this study were at either Norton Community Medical
Associates office or a Norton Children’s Medical Associates office located in the Louisville
metro office in a rural area.
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Informed consent
With the study being a retrospective chart review, obtaining informed consent was not
practical so a waiver of informed consent was approved via Institutional Review Board (IRB)
and Healthcare Systems Research Office.
Data Collection
The Health Systems Information Technology (IT) department randomly selected
electronic health records of 100 patients 11 to 18 years old who were seen at a Community
Medical Associates and 100 patients 11 to 18 years old who were seen at a Children’s Medical
Associates from January 1, 2017 through December 31, 2017 in the metro area. The primary
investigator (PI) reviewed the records to determine the level of provider adherence to ACIP/CDC
HPV vaccination guidelines. Data were collected on patient age and gender, type of clinic where
patient was seen (pediatric or family practice), if HPV vaccine was administered, and the number
of vaccine doses received. The electronic data collected were stored on a secured H-drive
firewall protected research folder at Norton Healthcare.
Data Analysis
Data analysis was conducted using IBM Statistical Software Analysis Package (SPSS).
Descriptive statistics were used to summarize the demographic characteristics of the study
sample from the chart review. Variations in vaccine rates based on demographic characteristics
were examined. Major themes were explored such as if one clinic had higher HPV vaccination
rates than the other or were similar and if parents/guardians are declining the HPV vaccination
for their child.
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Results
Sample characteristics
Of the 200 charts reviewed, 85 charts were excluded from the study. A total of 55 patients
in the family practice were excluded from study since they had already received their HPV
vaccination prior to January 1st, 2017. In the pediatric practice a total of 30 patients were excluded
since their HPV vaccination had already been given prior to January 1, 2017. Neither the family
nor pediatric practice had a patient excluded from the study due to contraindications/allergies to
the HPV vaccine. The total sample size included 115 patients, 70 from the pediatric practice and
45 from the family practice. Of the total sample (Table 1) the average age of patients in the
pediatric practice was 13.2 years (SD 1.9) and the average age of patients in the family clinic were
older at 14.1 years (SD 2.4) (p = 0.036). The family clinic saw an even spilt when it came to male
and female patients, males where slightly higher at 51 % and females at 48.9 %. The pediatric
practice saw more females at 58.6 % and the rest were males at 31.4%.
Vaccination Coverage
As seen in Table 1, the pediatric practice had a higher number of patients (68.6%) who
received the vaccine compared to the family practice (56.6 %). Despite the difference in
vaccination rates between the two clinics, it was not statistically significant (p= 0.157). To assess
the number of vaccinations received, 4 categories were divided to determine vaccination
coverage between both practices: first dose, second dose, third dose, and zero for no vaccination
given. When it came to the number of doses of vaccinations received, there were no significant
differences between the two practices (p= 0.407; Figure 2).
The ACIP/CDC guidelines indicate that a HPV series is complete when the patient has
received all the recommended doses based on patient’s age (2 doses before the age of 15, 3 doses
8
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for ages 15 or older). In the pediatric practice, 47.1% of the patients examined completed their
full HPV vaccination series per standards set by the ACIP compared to the family practice that
had a completion rate of 35.6%. Between the two practices (Table 1, Figure 3), there were more
patients that did not complete their full vacation series with the pediatric practice at 52.9% and
the family practice at 64.4% still needing to complete their HPV vaccination series. There was
no statistically significant difference between completion rates in the family and pediatric
practice (p=0.220).
Provider Adherence
Provider adherence to HPV vaccinations was also examined using the health maintenance
toolbar in the electronic medical record (EMR). The Health System uses EPIC as the electronic
medical record (EMR) system. Immunizations or preventive screenings appear in a health
maintenance toolbar at the top of the patient’s EMR and will prompt the provider on what
screenings and immunizations are needed based on the patient’s age. Currently, one of the prompts
in the health maintenance toolbar is the HPV vaccination series. During a patient encounter the
physician can click on the health maintenance toolbar and it would indicate if and when the patient
has received their HPV vaccination, along with the number of doses. This toolbar also provides an
option for the patient/parent to decline the HPV vaccination. If the vaccination is declined, the
provider will add “declined” in the HPV vaccination section of the health maintenance toolbar in
the patient’s EMR along with the date the vaccine was refused.
In the family clinic, the HPV vaccination was discussed 66.7 % of the time through the
documentation of the vaccination in the Health Maintenance Toolbar in the electronic medical
record (EMR) compared to 77.1 % of the time in the pediatric clinic. If the patient/guardian
declined the vaccination, then the provider was still adhering to the HPV vaccination guidelines
9
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despite the vaccination not being received by the patient. Out of 70 patient’s records reviewed the
in the pediatric practice, there were a total of 5 patients who declined the vaccination, compared
to the family practice with a total of 7 patients who declined. There were no statistically significant
differences in the rate at which providers addressed and were adherent to the HPV vaccination
guidelines (p=0.217).
The HPV vaccination is not a mandatory vaccination and patients/guardians have the right
to refuse to vaccinate. In the study’s family clinic setting, of those who did not receive the HPV
vaccination, 73% of the time the provider did not address or document anything in the health
maintenance toolbar. In the pediatric clinic setting, 65% of eligible patients in the sample did not
receive the vaccine. The amount of use of the health maintenance toolbar in the family and
pediatric setting did not reveal a statistical significance (p=0.586). Neither practice was able to
obtain the 80% goal set by Healthy People 2020 nor did the practices indicate a statistical
difference between the use of the toolbar. (Figure 1.).
Discussion
HPV vaccination rates have risen in the last decade, but more improvement is needed to
meet goal rates set by Healthy People 2020. This study aimed to identify if there were any
variations on vaccination rates or provider adherence to vaccination guidelines between a pediatric
clinic and a family clinic. This study concluded there is no statistical difference on how providers
are adhering to vaccination guidelines, the gender seen in the clinic, or the completion rate of the
HPV vaccination series. The mean age of the patients in the pediatric practice was younger at 13.2
years old, compared the family practice with a mean age of 14.1 years old (p=0.036).
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Provider recommendations play a huge role for parental decisions about HPV vaccinations.
With the help of EMR prompting providers to ask about the HPV vaccination during the preteen/adolescent visit helps increase the rates for HPV vaccinations. This study revealed the
importance of addressing the health maintenance toolbar in the EMR. Overall, providers in both
family and pediatric practices equally demonstrated a high rate of use of the health maintenance
toolbar when addressing the HPV vaccination during the patient’s visit, with the pediatric practice
even reaching 77.1%, almost at Healthy People 2020 80% goal set by the CDC. This study showed
that when the HPV vaccination was not addressed in the health maintenance toolbar fewer patients
received the vaccination. Of the 20 patients who did not receive the HPV vaccination in the family
practice, 73% of the time the provider not address the vaccination in the EMR. Of the 22 patients
who did not received the HPV vaccination in the pediatric practice, 65 % of the time the provider
did not document discussion about the vaccination in the EMR. Despite the increase in vaccination
rates over the years, there still are a high number of missed opportunities for HPV vaccinations.
This project also demonstrated that both practices had similar results to what is reported by
the CDC, over half of adolescents (66%) aged 13 to 17 have received at least the first dose of the
vaccination series and nearly 49 % of adolescents have received the full recommended doses to be
completed with the HPV vaccination series (CDC, 2018). In 2017, there had been a 6 % increase
of adolescents in the U.S. getting vaccinated for HPV from previous data from 2015. With the
newer ACIP vaccination guidelines, EMR prompts, and putting the focus on providers to
communicate the importance of the vaccination can help increase the initiation and completion
rates for the HPV vaccine.

11
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Limitations
This project had several limitations. The study was performed at a single pediatric primary
care clinic and one family practice clinic, therefore the findings cannot be generalized to a larger
population. The time constraints of the study limited data collection.

Only the patient’s

immunization records and health maintenance toolbar were used to assess provider adherence. Due
to the scope of this study, no education of the vaccination was reviewed and no reasons for the
patient/guardian declining the vaccination reasons were reviewed. Also, chart review was
performed randomly so that it was not determined whether it was an acute visit or a preventive
visit. Acute visits are shorter visits and generally only focused on one problem where preventive
well child visits are a longer office visit with the primary focus on prevention, such as: health
screenings and immunizations. Since this study’s primary focus was on provider adherence,
sample characteristics such as race and socioeconomic status were not examined. Lastly, due the
nature of this study being a retrospective chart review, there was no way to ensure that patient
information was entered the EMR correctly or if there was omission of data.
Implications for Practice
The literature shows how providers and provider recommendation play a critical role in
parents/guardians choosing to get their child vaccinated against HPV (Scott & Batty, 2016; Shay
et al., 2016; Sussman et al., 2015; Ylitalo, Lee, & Mehta, 2013;). When collecting the data for this
study, the most missed opportunities for not getting patients vaccinated where when the health
maintenance toolbar was not addressed by neither the provider nor someone in the medical staff.
Patients and parents/guardians have the right to make their own decision on HPV vaccinations but

12
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asking about and providing education on the vaccine can increase vaccination rates or possibly
compare to the rates of other adolescent vaccinations (such as Tdap and meningococcal vaccines).
These clinics should incorporate policy practice change where the medical team, along
with the provider, will assess the EMR and immunization records on every patient encounter.
Sussman et al. (2015) stated that most adolescent visits are usually episodic, which may provide
difficulty when offering or educating about the vaccine. Despite the time constraint of an acute
visit, it is still a patient encounter were immunizations can be reviewed and missed opportunities
can decreased. If the medical team, such as the medical assistant or nurse, assesses the patients’
immunization records while getting the patient ready to be seen by the provider these missed
opportunities can be decreased. Whether it is a preventive or an episodic visit for any patient who
meets the HPV vaccination age requirement, the vaccination should be discussed prior to the
encounter with the provider. Doing this will alert the provider if the HPV vaccination needs to be
discussed prior to entering the patient room and could increase the adherence and increase HPV
vaccination coverage. Once a system of collaboration like this is in place, it will become a part of
a daily work routine, thus increasing vaccination rates.
The CDC (2018) provides insight to many different ways clinics and providers can increase
HPV vaccination coverage. A potential strategy, and one that was highlighted in this study, was
the use of vaccination prompts that are available through electronic health records (CDC,
2018). Martin et al. (2015) demonstrated that EMR alerts improved HPV vaccine initiation rates
and completion rates tremendously compared to no prior previous prompts for the vaccination.
With the national average of HPV vaccination series completion being only 49 %, the CDC (2018)
also recommends scheduling appointments for the next dose before the patient leaves the clinic.
The CDC also suggests that a vaccination card be given to the patient prior to leaving the office
13
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that state when to return for the next dose. Additional recommendations include investigating
patient reminder systems such as: text messages, phone calls, or postcards to get a better
understanding on what is the most effective strategy to increase series completion rates.
Implications for Further Study
Data from this study showed that providers from both the pediatric clinical setting and the
family practice clinical setting had no significant difference when it came to adhering to HPV
vaccination guidelines. According to research there are many different interventions that have been
successful increasing HPV vaccinations rates. With providers being such a key component in the
decision-making process for most parents, barriers or obstacles providers face adhering to
vaccination guidelines should be explored. By examining these barriers, interventions can be
implemented to help overcome obstacles and improve adherence.
Conclusion
The goal of this study was to evaluate provider adherence for HPV vaccination in in both
a pediatric and family practice setting. While this study did not find any significant differences
between the two practices, it did find that some work is still needed to reach Healthy People 2020’s
goal of 80 % HPV vaccination coverage. Provider adherence is critical when it comes to HPV
vaccination rates. In this study, only 7.1 % of the patients in the pediatric practice declined the
vaccination and only 15.6 % declined in the family practice. In this study, 73 % of the time in the
family practice and 65 % of the time in the pediatric practice, there was no documentation of the
discussion of HPV vaccination in the health maintenance toolbar. Perhaps more patients would
have received the HPV vaccine if the provider had discussed it with them.

14
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The literature has shown parents trust provider’s recommendations when it comes to
immunizations and often is the biggest determinate when it comes to vaccinating their child. The
notion of perceived need in Andersen’s Health Behavioral Model implies that people view their
own general health and seek the advice of medical professional’s recommendations to help
produce positive healthcare outcomes (Andersen, 1995). In this study, when providers addressed
the need to the vaccination in the patient’s EMR, the perceived need was to listen to the
recommendation of the provider and get the HPV vaccination. Healthcare providers need to
remember the influence they have on parents/guardians for obtaining HPV immunizations. HPV
immunizations should be viewed as cancer prevention and providers should be recommending the
HPV vaccination to their patients in the same manner that they would when recommending a
mammogram or colonoscopy. Improving HPV immunization will lead to prevention of HPV
related diseases, especially the prevention of cancer, and provide optimal patient outcomes.

15
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Table 1. Demographic and clinical comparison of Pediatric clinic and Family clinic patients

Age (years)
Gender
Male
Female
HPV Vaccination
Given
Yes
No
Number of HPV
Vaccinations
received
Zero
First Dose
Second Dose
Third Dose
HPV addressed by
Provider in Health
Maintenance (EMR)
Yes
No
HPV Series
Completed
Yes
No
Vaccination Declined
Yes
No

Family (n =45)
Mean (SD) or n (%)
14.1 (2.4)

Pediatric (n= 70)
Mean (SD) or n (%)
13.2 (1.9)

p
(sig <0.05)
0.036

23 (51%)
22 (48.9%)

29 (41.4%)
41 (58.6%)

0.31

25 (55.6%)
20 (44.4%)

48 (68.6%)
22 (31.4%)

0.157

20 (44.4%)
9 (20%)
8 (17.8%)
8 (17.8%)

22 (31.4%)
14 (20%)
21 (30%)
13 (18.6%)

0.407

30 (66.7%)
15 (33.3%)

54.1 (77.1%)
16 (22.9%)

0.217

16 (35.6%)
29 (64.4%)

33 (47.1%)
32 (52.9%)

0.220

7 (15.6%)
38 (84.4%)

5 (7.1%)
65 (92.2%)

0.150
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Table 2. Frequency table on provider adherence clinical comparison
Adherence to HPV Guideline
Yes
No
P value = 0.467

Family (n= 45)
n (%)
32 (71.1%)
13 (28.9%)
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Pediatric (n= 70)
n (%)
54 (77.1%)
16 (22.9%)
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Figure 1. Percentage of patients who received the HPV vaccination in the pediatric clinic
(68.6%) and the family practice (55.6%) compared to the goal set by the CDC.
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Figure 2. Percentage of number of HPV vaccinations given in both pediatric (n=70) and family
clinic (n=45)
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Figure 3. Percentage of HPV vaccination serious completion set by ACIP/CDC guidelines in the
pediatric (n=70) and family clinic (n=45)
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